Revolutionizing Allergy & Immunology SMART on FHIR Prior Auth Workflows
Klivira streamlines **allergy & immunology SMART on FHIR prior auth** by embedding automation directly within the EMR, eliminating manual data entry and context-switching for high-volume biologics and immunotherapy requests.
For revenue cycle directors and prior authorization coordinators in allergy & immunology practices, the manual burden of prior authorization for high-cost therapies like biologics and IVIG is a significant operational challenge. Traditional workflows force clinicians and staff out of the EMR, leading to delays, errors, and increased administrative overhead. Klivira’s SMART on FHIR integration offers a powerful solution, bringing the PA process directly into the clinical workflow.
The Unique Prior Auth Challenges in Allergy & Immunology
Allergy & Immunology practices frequently manage prior authorizations for high-cost, specialty medications and procedures. Key categories include asthma biologics (e.g., Xolair, Dupixair, Nucala), IVIG/SCIG, and allergen immunotherapy. These therapies often require extensive clinical documentation and adherence to specific payer medical policies, making manual PA processes particularly arduous and prone to delays impacting patient care.
Traditional Prior Auth: A Disconnected and Costly Process
Without a SMART on FHIR-launched application, the typical prior authorization workflow in allergy & immunology involves significant context-switching. Clinicians or coordinators must navigate away from the EMR to separate payer portals or PA software, manually transferring patient demographics, member IDs, and clinical context. This fragmented approach frequently results in transcription errors, documentation gaps, and inconsistent write-back of PA outcomes, contributing to clinician burden and administrative costs.
Klivira's SMART on FHIR Workflow: Seamless Integration for A&I
- **In-EMR Launch:** Klivira launches directly from within the EMR (e.g., Epic Hyperspace, Cerner PowerChart, athenaOne, MEDITECH Expanse) via SMART App Launch, preserving clinical context.
- **Automated Context Transfer:** Patient and encounter data are automatically delivered via standard SMART parameters, eliminating manual data entry errors.
- **FHIR R4 Clinical Data Access:** Klivira reads US Core resources from the EMR's FHIR endpoint, ensuring accurate and comprehensive documentation assembly without screen-scraping.
- **Da Vinci Standard Execution:** Leveraging Da Vinci CRD for coverage discovery and Da Vinci PAS for submission, Klivira streamlines the entire PA lifecycle within the launched application.
- **Structured Outcome Write-Back:** PA decisions and status updates are written back to the EMR as structured FHIR resources (DocumentReference, Communication, Task), ensuring queryable and consistent record-keeping.
Addressing Key Failure Modes for Allergy & Immunology Prior Auth
Klivira's SMART on FHIR integration directly tackles the inefficiencies common in allergy & immunology prior authorization. By eliminating context-switching, automating data transfer, and leveraging FHIR R4 for documentation, we significantly reduce the administrative burden. This approach mitigates manual transcription errors and ensures that PA outcomes are consistently and structurally recorded within the patient's chart, improving data integrity and operational efficiency.
Leveraging Industry Standards: SMART on FHIR and Da Vinci PAS
Klivira's platform is built upon foundational industry standards to ensure robust and future-proof integration. We conform to the SMART App Launch IG for secure, context-aware EMR integration, and utilize US Core IG for standardized FHIR R4 resource exchange. For prior authorization, we implement the Da Vinci CRD, DTR, and PAS IGs, enabling automated coverage requirements discovery, documentation templating, and electronic submission directly from the clinical workflow. This adherence to standards ensures interoperability across major EMR vendors.
Frequently asked questions
How does SMART on FHIR specifically benefit prior authorization for biologics in Allergy & Immunology?
SMART on FHIR allows Klivira to launch directly from the EMR with patient context, automating the data collection for complex biologic prior auths like Xolair or Dupixair. This reduces manual data entry, ensures all required clinical documentation is pulled via FHIR R4, and facilitates submission via Da Vinci PAS, significantly accelerating approval times for these high-cost therapies.
Which EMR systems support SMART on FHIR for prior authorization workflows?
Klivira's SMART on FHIR integration is compatible with major EMR platforms that support the SMART App Launch IG. This includes systems such as Epic (Hyperspace/Hyperdrive), Cerner (PowerChart), athenahealth (athenaOne), and MEDITECH (Expanse). ONC Cures Update API certification requires SMART App Launch support, ensuring broad compatibility.
Can Klivira's SMART on FHIR solution handle both clinician-initiated and PA coordinator-initiated requests?
Yes, Klivira supports both EMR-launched workflows for clinicians and standalone-launched workflows for PA coordinators. While the EMR-launched context is ideal for in-chart initiation, our platform ensures that PA coordinators can also initiate and manage requests efficiently, leveraging the same automation capabilities even outside a direct patient-chart context.
What is the role of Da Vinci PAS in a SMART on FHIR prior authorization workflow for A&I?
Da Vinci PAS (Prior Authorization Support) defines the FHIR-based standards for submitting prior authorization requests. In a SMART on FHIR workflow, Klivira's application, once launched from the EMR, can leverage Da Vinci PAS to electronically submit the PA request directly to payers. This standardizes the submission process, improves data quality, and reduces reliance on faxes or proprietary payer portals for allergy & immunology procedures and medications.
How does Klivira ensure the security and privacy of PHI when using SMART on FHIR?
Klivira adheres to stringent security protocols, leveraging SMART on FHIR's OAuth 2.0 framework for secure authentication and authorization. Data exchange occurs over encrypted FHIR R4 endpoints, ensuring that all Protected Health Information (PHI) is handled in compliance with HIPAA guidelines. Our platform is designed with robust access controls and data encryption to safeguard patient data at every step of the prior authorization process.
Related coverage
Other allergy-immunology prior auth workflows
- Optimizing Allergy & Immunology Availity Integration for Efficient Prior Authorizations
- Automating Allergy & Immunology Biologics Prior Auth
- Optimizing Allergy & Immunology Prior Authorizations with Change Healthcare Clearinghouse
- Achieving Allergy & Immunology CMS-0057-F Compliance
- Optimizing Allergy & Immunology CoverMyMeds Integration
- Transforming Allergy & Immunology Prior Authorization with Da Vinci PAS
- Allergy & Immunology Denial Appeal Automation: Accelerate Revenue Capture
- Optimizing Allergy & Immunology Denial Management with Automation
- Optimize Allergy & Immunology Eligibility Verification Workflows
- Optimizing Allergy & Immunology eviCore Integration for Biologics and Advanced Imaging
- Automating Allergy & Immunology GLP-1 Prior Auth Workflows
- Automating Allergy & Immunology Imaging Prior Auth
- Optimizing Allergy & Immunology Oncology Pathways Prior Auth
- Streamlining Allergy & Immunology Payer Portal Automation
- Optimizing Allergy & Immunology Prior Authorization Automation
- Streamlining Allergy & Immunology Specialty Drug Prior Auth
Ready to automate this workflow for this specialty?
See how Klivira automates prior authorizations for your team.
Request a demo